Viewing Study NCT02132260


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-11 @ 10:29 PM
Study NCT ID: NCT02132260
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2014-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis
Sponsor: Sun Pharmaceutical Industries, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NFTC 1301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators